Salivart spray

Quick links

Choose a section

Quick links to important sections

Advertisements

Salivart spray

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of Salivart spray

The following quick facts define the identity and classification of Salivart spray.

Property Description
Active ingredients Electrolyte salts, Carboxymethylcellulose, Glycerin
Form Aerosol-spray (Oral/Mouth)
Pharmacological class Saliva substitute / Oral Moisturizer
Common use Relief of Dry mouth (Xerostomia)
Origin Synthetic and Aqueous Combination Product

What Type of Product is Salivart Spray? (Identity and Classification)

Salivart spray is classified as an Artificial Saliva product, which is a Synthetic Saliva Substitute and an Over-the-Counter (OTC) Oral Moisturizer. It is a device recognized by the FDA 510(k) K981693 and intended for the symptomatic management of Dry mouth (Xerostomia). It functions as a supportive Mouth and throat product designed to provide external moisture replacement, distinguishing it from prescription drugs that chemically stimulate residual salivary gland function. Its primary role is non-pharmacological replacement therapy, offering a supportive Saliva substitute option for patients with reduced salivary function.

Composition and Form: What is Synthetic Saliva Made Of?

The product is delivered as an Aerosol-spray formulation, utilizing an Aqueous base dispensed under pressure to ensure uniform coverage upon Oral/Mouth application. Salivart is a Combination product where the functional constituents include essential Electrolyte salts—such as Potassium Chloride and Sodium Chloride—engineered to approximate the ion profile of human saliva. The formula incorporates the polymer Carboxymethylcellulose and Glycerin to enhance viscosity, which is essential for improved Oral lubrication and a sustained protective effect on the oral mucosa.

General Purpose: What is Salivart Spray Used For?

The general purpose of the Saliva substitute is to deliver Oral lubrication and immediate Moistening/Hydrating oral mucosa to relieve the symptoms of discomfort associated with dryness in the mouth and Dry throat. By coating the oral tissues, the formulation creates a Protective film that effectively minimizes the friction and irritation accompanying severe Xerostomia. This action is aimed exclusively at providing symptomatic relief and improving the patient’s overall oral comfort, allowing individuals to speak and swallow with greater ease.

Regulatory References

  1. NIH MedlinePlus
Advertisements

What side effects are possible with Salivart spray?

Possible Side Effects and Safety Information

The safety profile for Salivart spray, classified as an oral saliva substitute device, focuses on the risk of hypersensitivity and localized effects at the site of application. Regulatory information for this product class typically lists possible reactions rather than applying standard frequency categories (e.g., common, uncommon) used for prescription drugs.


Localized and Systemic Adverse Reactions

Adverse effects noted for saliva substitutes relate mainly to the site of application and its components. These localized effects, categorized under Gastrointestinal Disorders (Oral/Pharyngeal), may include mouth irritation, abnormal taste, altered speech, or difficulty swallowing.

The most serious adverse reaction documented is the potential for a severe allergic reaction (hypersensitivity). Signs of a serious systemic response include rash, hives, wheezing, tightness in the chest or throat, difficulty breathing, or swelling of the face, lips, tongue, or throat.


Safety Restrictions and Considerations

The product is contraindicated in individuals with a known allergy to any of its components listed on the product package, representing a fundamental safety restriction. This restriction is the primary means of mitigating the risk of serious hypersensitivity.

Population-specific safety considerations include caution for patients on a low-sodium or sodium-free diet because the product contains sodium chloride. General discussion with a healthcare provider is noted for use during pregnancy and lactation.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The information concerning overexposure to Salivart spray, a synthetic saliva substitute, is strictly based on official regulatory documentation and focuses on mandated emergency actions. Due to the product's classification as an oral moisturizer composed of electrolyte salts and polymers, documented concerns primarily relate to volume rather than specific pharmacological toxicity.

Official Manifestations and Toxicity Profile

The primary event prompting regulatory guidance is the accidental ingestion of an unusually large quantity of the aqueous solution. Official labeling generally does not specify life-threatening systemic outcomes, such as severe cardiac or neurological toxicity, consistent with the product's non-systemic use. If symptoms do arise following a large ingestion, the officially documented manifestation is limited to non-specific gastrointestinal discomfort.

Mandatory Emergency Actions

Regulatory bodies explicitly mandate that individuals must seek immediate medical attention or contact a Poison Control Center immediately upon suspecting an accidental overexposure or ingestion of an excessive amount. This action is required regardless of whether symptoms have presented.

Required Management and Support

The official prescribing information confirms that no specific antidote is known to exist for this product. Management of overexposure is described as symptomatic and supportive treatment. In line with general safety protocols, clinical monitoring and observation may be advised by a healthcare professional following a reported ingestion to ensure stability. No specific population-based considerations regarding altered severity in pediatric or organ-impaired patients are explicitly detailed in the official overdose sections.

Advertisements

Therapeutic Uses of Salivart spray

What Salivart Spray Treats: Main Uses and Benefits

The primary therapeutic role of Salivart spray is symptomatic replacement therapy, providing supportive relief when symptoms interfere with routine activities. It is relevant in contexts marked by increased discomfort or tension. The product is considered relevant for easing symptoms that interfere with daily functioning, such as difficulties with speaking and swallowing. The product is intended to temporarily relieve discomfort of dry mouth and dry throat.

This product is commonly used for managing dry mouth associated with various clinical situations, including autoimmune diseases like Sjögren's Syndrome, dryness associated with head and neck radiation therapy, and dryness resulting as a side effect of numerous therapeutic agents. Salivart spray is applied in addressing symptom clusters that interfere with daily functioning, particularly the sticky feeling, soreness, and burning sensation in the mouth. This supportive symptomatic relief is relevant for easing associated difficulties with speech (dysphonia) and comfortable swallowing (dysphagia), supporting patients during difficult episodes by easing distress.

Quick Fact: Relief for Chronic and Episodic Oral Dryness (Xerostomia)

Regulatory References

  1. FDA 510(k) Summary for Salivart Oral Moisturizer
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Salivart Spray? (Official Eligibility)

Salivart spray is classified by the FDA as an Over-the-Counter (OTC) artificial saliva medical device, and its eligibility profile focuses on its intended use and local action.

General Eligibility Scope

Category Regulatory Status
Populations Allowed Individuals seeking temporary relief from dry mouth (Xerostomia) and dry throat.
Contraindications Patients with a known allergy or hypersensitivity to any of the product's listed ingredients (e.g., electrolyte salts, Carboxymethylcellulose, Glycerin).

Specific Population Considerations

  • Condition-Specific Rules: The product's non-systemic, local action means official regulatory labeling does not impose restrictions based on systemic conditions like hepatic or renal impairment.
  • Age-Related Eligibility: Use is generally established for adults and adolescents. Administration to younger children requires adult supervision to ensure correct, local oral application.
  • Pregnancy and Lactation: Official regulatory documentation does not formally restrict use during pregnancy or breastfeeding. However, as with all OTC products, consulting a healthcare professional is standard guidance before use.

Official Restrictions

Use of Salivart spray is strictly for oral application only and is not intended to be swallowed or used in the eyes. The primary eligibility exclusion is solely based on a documented allergy to any component of the formulation.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Salivart spray is defined by its classification as a non-pharmacological, topical saliva substitute that is not intended for systemic absorption. Consequently, official government regulatory documents do not list interactions involving metabolic enzymes, drug transporters, or resultant changes to systemic drug exposure.


Documented Interaction Profile Summary

Category Regulatory Status
Systemic Pharmacokinetic Interactions None documented.
Contraindicated Combinations None formally listed with other medicinal products.
Timing Separation Rules No mandatory separation rules documented for co-administration with other medicines.

Compositional and Dietary Consideration

The constraint for Salivart spray centers on its composition rather than pharmacological activity. The product contains electrolyte salts, including Sodium Chloride and Potassium Chloride. This requires consideration for individuals on a medically regulated low-sodium or sodium-free diet, as the product contributes to the total daily intake of these ions. This compositional relevance is noted in official regulatory-aligned information.


In summary, the interaction structure is characterized by the absence of systemic drug-drug interactions due to the product's local action, with the only specified constraint relating to its electrolyte content and relevance to dietary restrictions.

Advertisements

Mechanism of Action

The mechanism of Salivart spray is classified as biophysical replacement therapy, operating strictly on the surface of the oral mucosa rather than through pharmacological or biochemical signaling pathways. Its action is non-systemic, focusing on immediate, local modification of the physical environment in the mouth.


Establishing Viscoelastic Surface Lubrication

The spray's primary mechanism involves the immediate adhesion of Carboxymethylcellulose ( CMC) and Glycerin onto the epithelial cells. These components form an exogenous, viscoelastic film that physically substitutes for the diminished fluid layer of natural saliva. This mechanism directly reduces the coefficient of friction between moving oral surfaces, which reduces mechanical stress and abrasion associated with low surface lubricity.


Maintaining Epithelial Hydration and Ionic Balance

A complementary function is to ensure local hydration while maintaining osmotic balance. The aqueous base, fortified with essential Electrolyte salts (e.g., sodium and potassium chlorides), is formulated to match the physiological osmolality of native tissues. This action helps maintain the structural configuration of the mucosal surface by preventing the application of a non-buffered solution that might otherwise cause cellular fluid loss, thereby ensuring the lubricating film adheres to a physiologically hydrated base layer.


Non-Stimulatory Action and Mechanistic Limitations

The mechanism is non-pharmacological; it contains no agents that stimulate the M3 muscarinic receptors or the autonomic nervous system to induce natural salivary secretion. Consequently, the effect is transient, limited to the physical residence time of the water-soluble polymer film on the oral tissues before being cleared by swallowing, which limits the residence time and persistence of the biophysical action.

Advertisements

Dosage and Administration Information

Salivart spray is an aqueous aerosol formulation designed exclusively for oral, topical application within the mouth, intended to provide temporary relief as a saliva substitute. Its administration follows a pattern of intermittent use based on the patient's symptomatic need for relief, rather than a fixed, cyclical treatment schedule. Guidelines generally specify applying the product 3 to 5 times per day. However, administration frequency is permitted to be intensified to up to 10 times per day when managing dryness symptoms associated with high-demand contexts, such as those related to head and neck radiation therapy.

For proper application, the spray container should be shaken gently before each use to ensure the uniform dispersion of the formula. The product is applied directly to the tongue and into the oral cavity and is explicitly not intended to be swallowed, as its function is to create a protective topical coating. To preserve the effectiveness of this coating, patients are typically advised to avoid eating or drinking for approximately 15 minutes immediately following application. Furthermore, the administration of the spray to children requires adult supervision to ensure appropriate use. These application guidelines establish a high-level, non-systemic administration protocol focused on topical retention and symptomatic frequency.

Advertisements

Recent Clinical Evidence

Overview of Studies for Salivart Spray

Evidence on Symptomatic Relief of Dry Mouth (Xerostomia)

The research exploring saliva substitutes, like Salivart spray, primarily consists of short-term Randomized Controlled Trials (RCTs) and summaries called Systematic Reviews, which examine the use of these products in adults experiencing chronic dry mouth, or Xerostomia. The trials was studied for how symptoms change over time and what patient-reported outcomes describing perceived discomfort were measured. Studies report patterns related to short-term changes in the severity of dry mouth symptoms.

The research highlighted changes measured during the study period describing that the use of these artificial saliva products was associated with changes in patient reports of perceived comfort and oral moisture compared to using a placebo or water in the short term. The products research describes their function is to provide external lubrication. The nature of the patterns observed in the studies appears to be short-lived, often requiring frequent re-application, and this is reflected in the research duration.

Studies in Specific Patient Groups and Clinical Situations

Research studies explored the use of saliva substitutes in specific populations where chronic dry mouth is a major concern. These patient groups included those who have undergone Head and Neck Radiation Therapy for cancer and individuals with Autoimmune Diseases, such as Sjögren's Syndrome. The research explored the use of these products in outcomes capturing phases of heightened symptom activity and severe discomfort in these specific groups. The evidence contributes to understanding symptom patterns observed when artificial saliva is used in these conditions involving periods of heightened symptoms.

What is Still Uncertain About Saliva Substitute Research

A primary uncertainty is that comparative evidence is lacking between different brands and formulations of artificial saliva, including this specific type of spray. While the class of product was studied for symptom relief, research is not always consistent in describing which type of substitute is observed with different symptom patterns for all patients.

Furthermore, because the trials were generally short-term, the evidence provides context but not individual predictions regarding long-term relief. Long-term effects are not fully established regarding the continuous use of these substitutes over many months or years.

Key Studies & References

  1. Therapeutic strategies for dry mouth (xerostomia)
  2. Dry mouth: MedlinePlus Medical Encyclopedia
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Salivart spray (FAQ)

Q: What is Salivart spray used for?

A: Salivart spray is used to moisten and lubricate the mouth. According to the official product information, it is indicated to temporarily relieve the feeling of dry mouth, also known as xerostomia, which can occur for various reasons.

Q: How often can I use Salivart spray?

A: Regulatory documents state that Salivart spray is intended for use as often as needed to maintain moistness in the mouth. It is generally used to address the feeling of dry mouth whenever symptoms occur.

Q: What makes up Salivart spray?

A: The official product information indicates that Salivart spray contains electrolytes (sodium chloride, potassium chloride, calcium chloride, and potassium phosphate) and carboxymethylcellulose (CMC). These ingredients are included to help moisturize and lubricate the oral cavity.

Q: What happens if I accidentally swallow Salivart spray?

A: Studies and official information indicate that the product is intended for oral use, and it is not considered harmful if small amounts are accidentally swallowed. However, the product is primarily intended for topical application to the oral cavity.

Q: Can I use Salivart spray while wearing dentures?

A: Official information indicates that Salivart spray can be used by individuals who wear dentures. Its moisturizing function can help improve comfort, especially if dry mouth is a concern.

Q: Does Salivart spray contain sugar or alcohol?

A: According to the official product information, Salivart spray is formulated to be both sugar-free and alcohol-free. This is a key characteristic mentioned for maintaining general oral health while using the product.

Advertisements

How should Salivart spray be stored and disposed of?

Storage and Disposal Requirements for Salivart Spray

Salivart spray must be stored at room temperature, maintaining a required range of 59^circ to 86^circ F (15^circ to 30^circ C). The product is a pressurized container, and the regulatory labeling mandates that users avoid prolonged exposure to heat to ensure safety and stability. The container must be kept out of reach of children.

Container Handling and Disposal

Because the product is an aerosol, the official regulatory instructions for disposal are centered on safe container handling. Users are strictly prohibited from puncturing or incinerating the container. These instructions represent the primary regulatory guidance for safely discarding the used or expired product.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Salivart spray found in:

A-Z Index: